MIRVETUXIMAB SORAVTANSINE-GYNX (5563)    DRUG INGREDIENTS (50.416)

Name Value
NAME MIRVETUXIMAB SORAVTANSINE-GYNX
DRUG IDENTIFIER
  • 5679A32359
PRIMARY INGREDIENT MIRVETUXIMAB SORAVTANSINE
PGX ELIGIBLE NO
PGX SUPPRESSED NO
MASTER ENTRY FOR VUID YES
VUID 4041843
EFFECTIVE DATE/TIME
  • 2022-11-25 00:00:00
    STATUS:   ACTIVE